Aganodine

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H10Cl2N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 670P9AQR46, chemically known as guanidine, (4,7-dichloro-2-isoindolinyl)- but generally known as aganodine, which bears US NIH Compound Identifier 176878. European Medicines Agency schedules Aganodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05284MIG. The term AGANODINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). AGANODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aganodine under HS 29339990 and SITC 51577. As of Q4 2014, AGANODINE remains the US FDA Preferred Term for this commodity. Aganodine bears US NLM identifiers UMLS ID C2697894 and NCI Concept Code C74229. SMILES: C1C2=C(C=CC(=C2CN1N=C(N)N)Cl)Cl.